TrialBMC nephrology2024
A single-center, open label, randomized, controlled study of hydroxychloroquine sulfate in the treatment of low risk PLA
Mei Mei et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this paperpooled itcites it